Kci Medical Australia

Dietitian for Kids in Lane Cove West specializes in pediatric nutrition, offering expert guidance for infants to teenagers dealing with various medical conditions such as food allergies, fussy eating, and growth concerns. Led by Dr. Fiona Arrowsmith, an Accredited Practising Dietitian with over 25 years of experience, the practice emphasizes personalized support to help families turn stressful mealtimes into enjoyable experiences. In addition to one-on-one consultations, the practice addresses specialized diets, nutrient deficiencies, and complex health needs, ensuring that children receive tailored nutrition plans. Families can expect a collaborative approach, working alongside medical and allied health professionals to achieve optimal health outcomes for their children. Generated from the website

JDEN Services, located in Lane Cove West, New South Wales, specializes in providing innovative and high-quality equipment for physiotherapy, occupational therapy, and speech therapy, along with complete clinic fit-out services. They partner with therapists, clinics, and families across Australia to create environments that help children thrive, offering tailored solutions and expert support. The company also offers a range of training courses, including the Spider Cage course and Pedia Suit Therapy Protocol, to enhance clinical offerings. Additionally, JDEN Services provides financing options for acquiring therapy equipment, ensuring that clinics can manage cash flow while obtaining necessary resources for effective therapy solutions. Generated from the website

EnGeneIC, located in Lane Cove West, New South Wales, specializes in the research, development, and manufacturing of targeted anticancer therapies, utilizing a unique platform known as the EDV nanocell. This first-in-class cytoimmunotherapy technology targets tumors directly while harnessing the patient's own immune system for more effective treatment outcomes. Recently, EnGeneIC has made headlines by launching a groundbreaking clinical trial that evaluates the safety and efficacy of its EGFR-targeted EDV nanocells, which are designed to deliver a potent cytotoxic drug along with an immunostimulating adjuvant. With a commitment to advancing innovative cancer therapies, EnGeneIC is set to progress its novel platform technology from clinical trials to the market. Generated from the website